Nordmedics - Company finances
|
EUR
|
2024
From: 2024-07-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 246,574 | 742,212 |
| Profit before tax | - | - |
| Net profit | 12,466 | 122,652 |
| Equity | 15,366 | 138,018 |
| Liabilities | 41,936 | 188,985 |
| Non-current assets | 0 | 4,174 |
| Current assets | 57,302 | 322,829 |
| Total assets | 57,302 | 327,003 |
|
Taxes paid
|
||
| STI taxes | 44,538 | 100,063 |
|
Financial indicators
|
||
| Revenue change y/y | - | +201.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 21.8% | 37.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 81.1% | 88.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.1% | 16.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.7 | 1.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 246,574 | 556,673 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Nordmedics - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-02-10 | 2025-02-10 | 0.01 |
| 2025-01-22 | 2025-02-04 | 0.01 |
| 2024-12-17 | 2024-12-20 | 4.38 |
| 2024-10-16 | 2024-10-20 | 10.64 |
Nordmedics - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-30 | 2026-06-30 | 1190.37 |
| 2026-06-28 | 2026-06-29 | 1190.62 |
| 2026-05-15 | 2026-05-25 | 65.59 |
| 2026-05-01 | 2026-05-07 | 69.84 |
| 2026-04-30 | 2026-04-30 | 69.82 |
| 2026-04-17 | 2026-04-20 | 69.24 |
| 2026-02-21 | 2026-02-21 | 68.67 |
| 2026-02-03 | 2026-02-16 | 140.64 |
| 2026-01-31 | 2026-02-02 | 140.44 |
| 2026-01-29 | 2026-01-30 | 140.48 |
| 2026-01-16 | 2026-01-20 | 140.0 |
| 2026-01-08 | 2026-01-15 | 69.41 |
| 2026-01-01 | 2026-01-07 | 69.29 |
| 2025-12-31 | 2025-12-31 | 0.24 |
| 2025-12-17 | 2025-12-23 | 68.59 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Nordmedics, UAB (code 306897816) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the latest financial year, the company generated revenue of €742.2K and net profit of €122.7K, resulting in a profit margin of 16.5%. Revenue increased by 201.0% year on year, showing a strong expansion from €246.6K in 2024. Net profit also rose materially from €12.5K in 2024 to €122.7K in 2025, indicating a significant improvement in operating performance. The balance sheet strengthened during the year: total assets increased to €327.0K, equity reached €138.0K, and liabilities stood at €189.0K. The equity ratio was 42.2%, with a debt-to-equity ratio of 1.37. Return on equity was 88.9% and return on assets 37.5%, while asset turnover reached 2.27x. Revenue per employee was €742.2K and profit per employee €122.7K, pointing to strong productivity in 2025.